BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1638083)

  • 1. Skin cancers and HLA frequencies in renal transplant recipients.
    Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
    Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
    Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
    J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple nonmelanoma skin cancer associated with HLA DR7 in southern Australia.
    Czarnecki DB; Lewis A; Nicholson I; Tait B
    Cancer; 1991 Jul; 68(2):439-40. PubMed ID: 2070340
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
    Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
    Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between skin cancer and HLA antigens in renal-transplant recipients.
    Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
    N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.
    Bouwes Bavinck JN; Kootte AM; Van Der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
    J Invest Dermatol; 1991 Aug; 97(2):269-72. PubMed ID: 1649229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple basal cell carcinomas and HLA frequencies in southern Australia.
    Czarnecki D; Lewis A; Nicholson I; Tait B
    J Am Acad Dermatol; 1991 Apr; 24(4):559-61. PubMed ID: 2033130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA and multiple skin carcinomas.
    Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
    Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations.
    Gutiérrez-Dalmau A; Revuelta I; Ferrer B; Mascaró JM; Oppenheimer F; Albanell J; Campistol JM
    Transplantation; 2010 Nov; 90(9):986-92. PubMed ID: 20844469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple non-melanoma skin cancer: evidence that different MHC genes are associated with different cancers.
    Czarnecki D; Tait B; Nicholson I; Lewis A
    Dermatology; 1994; 188(2):88-90. PubMed ID: 8136554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-specific serum antibodies are not associated with a history of skin carcinoma in renal transplant recipients and immunocompetent individuals.
    de Graaf YG; Schiefer D; Redeker A; Vermeer BJ; Bavinck JN; Willemze R; de Gruijl FR; Van der Burg SH
    J Dermatol Sci; 2005 Jun; 38(3):228-30. PubMed ID: 15927816
    [No Abstract]   [Full Text] [Related]  

  • 12. T6+ and HLA-DR+ cell numbers in epidermis of immunosuppressed renal transplant recipients.
    Kelly G; Scheibner A; Murray E; Sheil R; Tiller D; Horvath J
    J Cutan Pathol; 1987 Aug; 14(4):202-6. PubMed ID: 3114340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
    Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
    Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA DR4 is associated with the development of multiple basal cell carcinomas and malignant melanoma.
    Czarnecki D; Nicholson I; Tait B; Nash C
    Dermatology; 1993; 187(1):16-8. PubMed ID: 8324271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin cancer in Australian heart transplant recipients.
    Ong CS; Keogh AM; Kossard S; Macdonald PS; Spratt PM
    J Am Acad Dermatol; 1999 Jan; 40(1):27-34. PubMed ID: 9922009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and skin cancer.
    Bonamigo RR; Carvalho AV; Sebastiani VR; Silva CM; Pinto AC
    An Bras Dermatol; 2012; 87(1):9-16; quiz 17-8. PubMed ID: 22481646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positivity for HLA DR1 is associated with basal cell carcinoma in renal transplant patients in southern Brazil.
    de Carvalho AV; Bonamigo RR; da Silva CM; Pinto AC
    Int J Dermatol; 2012 Dec; 51(12):1448-53. PubMed ID: 23171011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA phenotypes and multiple basal cell carcinomas.
    Rompel R; Petres J; Kaupert K; Mueller-Eckhardt G
    Dermatology; 1994; 189(3):222-4. PubMed ID: 7949471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence for an association of HLA-DR7 with basal cell carcinoma on the tropical island of Saba.
    Bavinck JN; Bastiaens MT; Marugg ME; Beckers RC; Westendorp RG; Vermeer BJ; Claas FH
    Arch Dermatol; 2000 Aug; 136(8):1019-22. PubMed ID: 10926738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.